adakveo
(crizanlizumab)Novartis Pharmaceuticals Corporation
Usage: ADAKVEO® is indicated for reducing the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 and older with sickle cell disease.
Novartis Pharmaceuticals Corporation drugs
72 results
afinitor - everolimus tablet
(Everolimus)Novartis Pharmaceuticals Corporationarranon - nelarabine injection
(Nelarabine)Novartis Pharmaceuticals Corporationarzerra - ofatumumab injection, solution
(Ofatumumab)Novartis Pharmaceuticals Corporationazopt - brinzolamide suspension/ drops
(Brinzolamide)Novartis Pharmaceuticals Corporationbeovu
(brolucizumab)Novartis Pharmaceuticals CorporationUsage: BEOVU® is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).betoptic s
(betaxolol hydrochloride)Novartis Pharmaceuticals CorporationUsage: BETOPTIC S (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.cipro
(Ciprofloxacin Hydrochloride And Hydrocortisone)Novartis Pharmaceuticals Corporationciprodex - ciprofloxacin and dexamethasone suspension/ drops
(Ciprofloxacin And Dexamethasone)Novartis Pharmaceuticals Corporationcoartem - artemether and lumefantrine tablet
(Artemether And Lumefantrine)Novartis Pharmaceuticals Corporation